Page 5 - Use Authorization News Today

PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its

Fear is big business. When it comes to selling 270 million American “sheeple” on getting jabbed up with the most dangerous injections ever invented, fear was the number one “marketing” factor. Once Covid-19 began spreading, the narrative heard around the world was that it was quite deadly and very contagious. The only way to protect […]

New legislation recently proposed in San Francisco would facilitate the conversion of office buildings to residential and other newly permitted uses. Pending state legislation would...

PRINCETON, N.J., June 15, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its... | June 15, 2023

The vaccine manufacturer in 2017 knew it needed a way to boost its profits as it struggled to stay in the black, reports reveals.

New San Francisco legislation aims to streamline permitting process for small businesses, encourage new businesses to open

Cue’s COVID-19 Molecular Test detects all known variants of concern and seamlessly integrates with Cue Care, the company’s innovative test-to-treatment platform ... | June 6, 2023

Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test Cues COVID-19 Molecular Test... | June 6, 2023

Seraph 100 Featured as Primary Therapy for Extracorporeal Blood Purification ExThera Medical, a healthcare company that has developed and commercialized a unique extracorporeal blood filtration medical

FinancialContent fully hosted finance channel